JPRN-jRCTs031210583进行中（未招募）未知
An open-label, randomized controlled trial of Ninjin'yoeito in COPD patients with fatigue - RCT of NYT in COPD
Ohbayashi Hiroyuki0 个研究点目标入组 60 人开始时间: 2022年1月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) COPD patients with stage II or higher who are visiting the research facility
- •2) Patients who have continued standard treatment for 4 weeks or more by the time consent is obtained
- •3) Patients with stable respiratory symptoms
- •4) Patients with fatigue
- •5) Patients who have written consent to participate in this study
- •6) Age: 20 years or older
排除标准
- •1) Patients diagnosed with respiratory diseases other than COPD such as asthma (excluding ACO)
- •2) Patients who newly started pulmonary rehabilitation within 3 months before the start of this study (excluding physical therapy)
- •3) Patients who have newly started respiratory rehabilitation since the start of this study (excluding physical therapy)
- •4) Patients who changed the content and frequency of respiratory rehabilitation during this study
- •5) Patients suffering from acute exacerbations and acute diseases within 4 weeks prior to the start of this study
- •6) Patients with significant locomotor system / central nervous system disease / neuromuscular disease that affect walking ability
- •7) Patients with significant neuromuscular disorders due to central nervous system diseases such as cerebral infarction
- •8) Patients who took Kampo medicine within 4 weeks before the start of this study
- •9) Patients who have been treated for malignant tumors within 5 years before the start of this study or are currently being treated
- •10) Patients with serious comorbidities (liver disease, renal disease, heart disease / blood disease, etc.)
- •11) Patients who have experienced drug allergies due to Kampo medicines in the past
- •12) Patients with dementia who cannot answer the questionnaire
- •13) Patients with significantly poor drug adherence
- •14) Pregnant / lactating women and patients undergoing fertility treatment
- •15) Patients who was judged to be inadequate according to the judgment of the examination medical attendant
研究者
相似试验
招募中
Unknown
injinyoeito for nontuberculous mycobacterial pulmonary disease with weight loss and anorexiaJPRN-jRCTs031220576Morimoto Kozo50
招募中
4 期
A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)ITMCTR2000003035The First Affiliated Hospital of Nanchang University
已完成
4 期
A comparative study of the effects of Liraglutide and Acarbose on glycaemic control, weight and Health Related Quality Of Life (HRQOL) in Overweight type 2 Diabetic patients on Oral Hypoglycaemic Agents (OHAs) and high doses of insulin.ISRCTN47355247West Wales Hospital (UK)66
尚未招募
不适用
A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patientshyperuricemic nephropathy at CKD stages 3-4ITMCTR2100005088Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
尚未招募
3 期
A prospective, randomised, open label trial on the effect of metformin on in-vitro fertilisation outcome in women with polycystic ovary syndromePolycystic ovary syndromeReproductive Health and Childbirth - Fertility including in vitro fertilisationMetabolic and Endocrine - Other metabolic disordersInfertilityACTRN12609000510246Fertility Society of Australia124